Amastatin

Edit links
Source: Wikipedia, the free encyclopedia.
Amastatin
Clinical data
ATC code
  • None
Identifiers
  • (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-3-Amino-2-hydroxy-5-methylhexanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]butanedioic acid
JSmol)
  • CC(C)CC(C(C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(=O)O)C(=O)O)O)N
  • InChI=1S/C21H38N4O8/c1-9(2)7-12(22)17(28)20(31)25-16(11(5)6)19(30)24-15(10(3)4)18(29)23-13(21(32)33)8-14(26)27/h9-13,15-17,28H,7-8,22H2,1-6H3,(H,23,29)(H,24,30)(H,25,31)(H,26,27)(H,32,33)/t12-,13+,15+,16+,17+/m1/s1
  • Key:QFAADIRHLBXJJS-ZAZJUGBXSA-N

Amastatin, also known as 3-amino-2-hydroxy-5-methylhexanoyl-L-valyl-L-valyl-L-aspartic acid, is a

endogenous peptides.[8]

See also

References

  1. ISBN 978-0-412-46620-5
    .
  2. PMID 10985965
    .
  3. ISBN 978-0-8493-4985-0
    .
  4. ISBN 978-3-11-014535-9
    .
  5. ISBN 978-1-4831-9033-4
    .
  6. ISBN 978-94-009-4832-7
    .
  7. S2CID 3881661
    .
  8. PMID 8390390
    .


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Amastatin&oldid=1206991292"